Clinical T

This input is used for staging

Notes

**Note 1:** When both the Federation Internationale de Gynecologie et d'Obstetrique (FIGO) stage and extension information on the primary tumor are available, use the extension information to assign the T in preference to a statement of FIGO stage - see Registrar notes. * If the only information is FIGO III [NOS] or IIIC, assign the appropriate stage and leave clinical T, N, and M blank. If the only information is FIGO stage IV, leave T and N blank and see M **Note 2:** FIGO does not include an in situ category for tumors of the fallopian tube, but TNM does. Assign pTis (behavior code /2) for in situ cases. **Note 3:** Liver capsule metastasis is T3/Stage III, liver parenchymal metastasis, M1/Stage IV. **Note 4:** Both extension to and discontinuous metastasis to any of the following pelvic organs are assigned as FIGO Stage II and coded in T2a or T2b. * Adnexa, NOS; bladder, bladder serosa; broad ligament (mesovarium); cul de sac; contralateral fallopian tube; parametrium; pelvic peritoneum; pelvic wall; rectum; sigmoid colon; sigmoid mesentery; ureter; uterus; uterine serosa **Note 5:** Both extension to and discontinuous metastasis to any of the following abdominal organs are classified as FIGO Stage III and coded in T3. * Abdominal mesentery; diaphragm; gallbladder; infracolic omentum; kidneys; large intestine except rectum and sigmoid colon; liver (peritoneal surface); omentum; pancreas; pericolic gutter; peritoneum, NOS; small intestine; spleen; stomach; ureters

NAACCR Item

NAACCR #940
Clinical T Clinical T Display Description Registrar Notes
cX cTX Primary tumor cannot be assessed Clinical classification criteria met, evaluation done:
Physician unable to assess T
Extension cannot be determined OR
Physician assigns cTX, no other information available to determine T
c0 cT0 No evidence of primary tumor
pIS pTis Carcinoma in situ (preinvasive carcinoma) In situ, intraepithelial, noninvasive
Limited to tubal mucosa

Stated as Tis
c1 cT1 Tumor confined to fallopian tube(s) Note: T1 has subcategories of T1a, T1b and T1c. Assign T1 only when there is no information available to assign one of the subcategories

Confined to fallopian tube, NOS
Localized, NOS

FIGO Stage I [NOS]

Stated as T1
c1A cT1a Tumor limited to one tube
WITHOUT penetrating the serosal surface
Confined to one fallopian tube
WITHOUT penetrating serosal surface
WITHOUT ascites

FIGO Stage IA

Stated as T1a
c1B cT1b Tumor limited to both tubes
WITHOUT penetrating the serosal surface
Confined to both fallopian tubes
WITHOUT penetrating serosal surface
WITHOUT ascites

FIGO Stage IB

Stated as T1b
c1C cT1c Tumor limited to one or both tube(s)
WITH extension onto or through the tubal serosa, OR
WITH malignant cells in ascites or peritoneal washings
Extension onto or through tubal serosa
Malignant ascites
Malignant peritoneal washings

FIGO Stage IC

Stated as T1c
c2 cT2 Tumor involves one or both fallopian tube(s) with pelvic extension Note: T2 has subcategories of T2a, T2b and T2c. Assign T2 only when there is no information available to assign one of the subcategories

Pelvic extension, NOS with no malignant cells in ascites or peritoneal washings

FIGO Stage II [NOS]

Stated as T2 [NOS]
c2A cT2a Extension and/or metastasis to uterus and/or ovaries Extension or metastasis to:
Corpus uteri
Ovary, ipsilateral or contralateral
Uterus, NOS
WITHOUT malignant cells in ascites or peritoneal washings

FIGO Stage IIA

Stated as T2a
c2B cT2b Extension to other pelvic structures Extension or metastasis to:
Adjacent peritoneum
Broad ligament, ipsilateral or contralateral
Cul de sac (rectouterine pouch)
Mesosalpinx, ipsilateral or contralateral
Rectosigmoid
Sigmoid
WITHOUT malignant cells in ascites or peritoneal washings

FIGO Stage IIB

Stated as T2b
c2C cT2c Pelvic extension (2a or 2b)
WITH malignant cells in ascites or peritoneal washings
FIGO Stage IIC

Stated as T2c
c3 cT3 Tumor involves one or both fallopian tube(s)
WITH peritoneal implants outside the pelvis and/or positive regional lymph nodes
Note: T3 has subcategories of T3a, T3b and T3c. Assign T3 only when there is no information available to assign one of the subcategories

Peritoneal implants or metastasis outside the pelvis, size of metastasis not stated, unknown if microscopic or macroscopic:
Omentum
Small intestine

Further contiguous extension

Stated as T3 [NOS]
c3A cT3a Microscopic peritoneal metastasis outside the pelvis Microscopic peritoneal implants or metastasis:
Omentum
Small intestine

FIGO Stage IIIA

Stated as T3a
c3B cT3b Macroscopic peritoneal metastasis outside the pelvis, 2 cm or less in greatest dimension FIGO Stage IIIB

Stated as T3b
c3C cT3c Peritoneal metastasis, more than 2 cm in greatest dimension AND/OR
Positive regional lymph nodes
Stated as T3c
88 88 Not applicable Primary site/histology not TNM defined
Death certificate only (DCO) case
<BLANK> BLANK See Registrar Notes Only information is FIGO Stage III [NOS], IIIC or IV

Clinical classification not met
Clinical classification criteria met, evaluation done:
No information about diagnostic workup
Results not documented in record
Clinical evaluation of primary tumor not done or unknown if done
Tumor first detected on surgical resection (no clinical workup)
Evidence of metastatic disease [(cM1) or (pM1)], no other workup